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The organometallic RuII arene complex [(h6-tha)Ru(en)Cl]+ (1), where tha¼ tetrahydroanthracene and
en ¼ ethylenediamine, is potently cytotoxic towards cancer cells. We have used a combination of
HPLC, ESI-MS, 1D- and 2D-NMR, including [1H, 1H] ROESY, NOESY, [1H, 15N] HSQC (using
15N-1), and [1H, 31P] experiments to elucidate the role of the non-aromatic, bulky rings of tha in adducts
with the DNA hexamer d(CGGCCG), since DNA is a potential target for this drug. Reactions of 1 with
single-stranded d(CGGCCG) gave rise to ruthenation at each of the three G bases, whereas reactions of
the duplex d(CGGCCG)2 with 1 mol equiv. 1 led to exclusive ruthenation of G
3 and G6 (and G9, G12)
and not G2 (or G8). Addition of a second mol equiv. of 1 gave di-ruthenated adducts (major sites G3/G6,
G6/G9, G2/G6), and on reaction with a third mol equiv. tri-ruthenation (G2, G3/G6/G12).The NMR data
are indicative of the coordinative binding of Ru-tha specifically to G3 and G6, together with penetrative
intercalation of the bulky non-coordinated tha rings B and C of 10, selectively between two base pairs
G3/C10:C4/G9 and G6/C7:C5/G8. Intercalation at GpC base steps by tha has a lower energy penalty
compared to intercalation at GpG base steps, thereby allowing accommodation of tha. Mono-
intercalation of tha reduced the strength of H-bonding between en-NH and GO6. These differences in
structural distortions compared to cisplatin induced by the coordinative binding of Ru-tha to GN7 may
contribute to the differences in mechanism of action, including protein recognition of the metallated
lesions, and lack of cross resistance.
Introduction
There is currently much interest in the design and mechanism of
action of ruthenium anticancer complexes.1–7 Structural distor-
tions of DNA are thought to play a major role in the anticancer
activity of many ruthenium and other transition metal
complexes.1,8–23 It is apparent that distortions induced in DNA
by [(h6-arene)Ru(en)Cl]+ organometallic ruthenium(II) arene
anticancer complexes1,21,24–28 (en ¼ ethylenediamine) differ
significantly from those induced by cisplatin.9,10 In particular the
arene appears to play a significant role in DNA interactions and
the cytotoxicity of complexes shows a strong dependence on the
arene.19,22,23,29,31 The cytotoxic activity of these ruthenium arene
complexes appears to increase with the size of the coordinated
arene:1,24,25 p-cymene (Ru-cym) < biphenyl (Ru-bip) < dihy-
droanthracene (Ru-dha) < tetrahydroanthracene (Ru-tha, 1,
Fig. 1), the latter complex being as cytotoxic as the clinical
platinum drug cisplatin. If the arene is extended, the possibility
arises of intercalation between DNA base-pairs. Studies of the
interactions of ruthenium complexes Ru-cym and Ru-bip with
the 6-mer duplex d(CGGCCG)2 revealed that the binding of Ru
to GN7 is accompanied by strong H-bonding between GO6 and
en-NH, and that the arene ligand distorts the duplex either via
steric interactions (Ru-cym) or via intercalation19,22,23,32,38
(Ru-bip), which may explain why the IC50 values of complexes
Ru-cym and Ru-bip are similar.1,24,25 Further work23 revealed
Fig. 1 Structures and NMR numbering schemes for [(h6-tha)Ru(en)Cl]+
(1) and for the 50-d(CpGp) fragment of the hexamer d(CGGCCG);
single-strand (ss) I and duplex II.
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a unique mode of binding of Ru-bip to a 14-mer DNA duplex:
the monofunctional fragment {(h6-biphenyl)Ru(en)}2+ is highly
specific for GN7, although mobile at elevated temperature
(migrating to other G residues). The uncoordinated phenyl ring
of bip can be involved in p–p stacking with DNA bases either via
classical intercalation19,35–38 between the bases, or with a partially
extruded T base.23,39,40
Arene–base stacking may play a role in determining the rates
of reactions of RuII arene complexes with DNA, as appears to be
the case for mononucleotides. We have shown previously that the
tha and bip arenes can exert slightly different effects on the
chemical reactivity of these RuII complexes and on distortions
induced in DNA.26,29,30 For example the rate of reaction of Ru-
bip with cGMP is ca. 2 slower than that of 1,27 but Ru-bip
induces similar unwinding of DNA as complex 1 (14).26 Both of
these complexes can potentially intercalate into DNA, leading to
‘‘downstream’’ effects on DNA processing and repair mecha-
nisms. Ru-bip is an aromatic intercalator,22,23,41 in which all the
protons of the extended ring are within the aromatic plane, and
can form p–p interactions with bases; however, the extended
rings B and C of tha in 1 are bulky non-aromatic groups; the
three rings A, B and C are not in the same plane and the H5,8 and
H9,10 protons are located above or below the arene ring plane by
nearly 0.9 A. The extended rings B and C cannot form p–p
interactions with bases in the same way that aromatic inter-
calators do and so Ru-tha is more sterically demanding than Ru-
bip. It is reasonable to predict that the intercalative interactions
between duplex DNA and Ru-tha or Ru-bip should be quite
different. The Ru-tha complex 1 is 10 times more toxic to cancer
cells than Ru-bip.24,25
Bulky substituents at the sites of DNA lesions may activate
nucleotide-excision repair;42,43 however, reports of intercalation
by bulky molecules are rare. Gomez-Pinto et al.44 have shown
that intercalation of a modified nucleotide containing a choles-
terol derivative into a DNA decamer induces DNA distortions
which are different from those induced by aromatic inter-
calators.45,46
Threading intercalation has attracted recent attention
because the intercalator occupies and interacts strongly with
both the minor and major grooves of DNA simultaneously.
This has been observed for polyaromatic intercalators,47–49
dinuclear metallointercalators,50–53 and platinum complexes
with aromatic side-arms, such as acridine-9-ylthiourea.54–56 As
a result, threading intercalative interactions promise high
DNA binding affinity and specificity, a slow rate of dissoci-
ation, and an enhanced ability to block DNA–protein inter-
actions.50,57
It is important to understand the mode of interaction
between [(h6-tha)Ru(en)Cl]+ (1) and DNA since a major
contributor to its high potency appears to be the lack of repair
of the lesions formed on DNA by this complex,29 i.e. lack of
recognition by repair enzymes. In the present work we have
investigated the role of the extended non-aromatic bulky tha in
interactions of [(h6-tha)Ru(en)Cl]+ (1) with the single-stranded
hexamer d(CGGCCG) and double-stranded duplex
d(CGGCCG)2 using a wide variety of experimental techniques
including HPLC, ESI-MS and 1D 1H and 2D [1H,1H] ROESY,
NOESY, [1H, 15N] HSQC (using 15N-1), and [1H, 31P] NMR
spectroscopy.
Results
Scheme 1 indicates the reaction pathways that were followed
during the course of this study. HPLC enabled separation of
single DNA strands even for reactions of the duplex. The 1 : 1,
2 : 1 and 3 : 1 1/I mixtures, 1.1 : 1 and 2 : 1 1/II mixtures were
studied by HPLC and ESI-MS, and 1.1 : 1, 2 : 1 and 3 : 1 1/II
mixtures were studied by 1D 1H and 2D [1H, 1H] TOCSY NMR
experiments. The 1.1 : 1 1/II mixture was studied by 1D 1H, 2D
15N-decoupled [1H, 1H] ROESY, NOESY, 15N-edited [1H, 1H]
TOCSY and NOESY, 2D 15N-decoupled [1H, 15N] and [1H, 31P]
HSQC NMR experiments using 15N-en labelled 1. A near-
complete NMR spectral assignment of the NOESY NMR
spectrum of the 1.1 : 1 1/II mixture was achieved, although its
complexity precluded full structure determination. Assignments
were made possible by the known selectivity of 1 for guanines,
and the localization of structural perturbations to residues close
to the ruthenated G residue. Thus, sequential assignments along
each strand always led to cross-peaks largely identical to those of
the non-ruthenated duplex. Despite extensive overlap of NOE
cross-peaks, little ambiguity in the assignments of individual
resonances was found, with cross-validation of signal assign-
ments from related connectivities being possible, with the help of
[1H, 31P] HSQC, [1H, 15N] HSQC and 15N-edited [1H, 1H] NOESY
Scheme 1 (A) Reaction of single-stranded (ss) hexamer I (0.1 mM) with
1 mol equiv. of 1 in H2O, 310 K for 48 h, gives three mono-ruthenated I
(I-Ru-G2, I-Ru-G3, I-Ru-G6). (B) Reaction of double-stranded (ds)
hexamer II (0.3 mM, 0.1 M NaClO4) with 1.1 mol equiv. of 1 in 90% H2O/
10% D2O gives rise to two mono-ruthenated duplexes II-Ru-G
3 and
II-Ru-G6 as products. Addition of a second mol equiv. of 1 results in di-
ruthenated duplexes, including II-Ru2-G
3G6, II-Ru2-G
6G9 and II-Ru2-




products. Ru ¼ {(h6-tha)Ru(en)}2+, 10. For structure of 1, see Fig. 1.
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experiments and HPLC-MS data. 2D 15N-decoupled [1H, 1H]
ROESY and NOESY and 15N-decoupled [1H, 15N] HSQC NMR
data were also acquired for 2 : 1 and 3 : 1 1/II mixtures, but the
spectra were too complex for interpretation.
HPLC and ESI-MS characterization of products from ss-DNA
I + 1
A 100 mM aqueous solution of 1 was incubated with I at 310 K at
Ru : I molar ratios of 1 : 1, 2 : 1 and 3 : 1 for 48 h in the dark,
and these were then analyzed by HPLC. The low ionic strength
(5.1  104 M) ensures that this self-complementary oligonu-
cleotide remains largely single-stranded (calculated melting
temperature 264 K) under these conditions.58 New peaks were
observed for each reaction (Fig. 2 and Table S1†), and the
adducts associated with them were identified subsequently by
ESI-MS. The peaks for the observed negative ions are listed in
Table S1.† Reaction at a Ru : I molar ratio of 1 : 1 resulted in
three mono-ruthenated products together with three di-ruthen-
ated products. Reaction at a Ru : I molar ratio of 2 : 1 resulted in
three di-ruthenated products together with a tri-ruthenated
product. Reaction at a Ru : I molar ratio of 3 : 1, gave only one
main HPLC peak corresponding to a tri-ruthenated product.
HPLC and ESI-MS characterization of products from reaction
of duplex II + 1
An aqueous solution of 1 was incubated with duplex II in 0.1 M
NaClO4 at ambient temperature for 24 h at a Ru : II molar ratio
of 1.1 : 1 in an NMR tube in the dark. This gave rise to HPLC
peaks which were identified by ESI-MS as ss-DNA I and two
mono-ruthenated single-stranded products (see Fig. 2(d),
Table S1†), with relative peak area ratios of 2 : 1. Another
equimolar amount of 1 was then added to give a Ru : II molar
ratio of 2 : 1, and was kept at ambient temperature in the dark
for 48 h. This gave HPLC peaks which were identified by ESI-
MS as two mono-ruthenated and two di-ruthenated single-
stranded products (see Fig. 2(e) and Table S1†).
NMR characterization of products
Assignments of the 1H NMR peaks for the ruthenated DNA
duplexes were made on the basis of established methods devel-
oped for studying right-handed B-DNA duplexes by NMR
spectroscopy.59 The assignments of the 1H NMR resonances of
free DNA duplex II have been reported by Lam and Au-Yeung60
and the 1H and 31P chemical shifts are listed in Table S2.†
Terminal (30) base resonance assignments were identified from
NOESY NMR data sets and were based on ordering of the H20
and H20 0 proton chemical shifts (H20 > H20 0) compared with the
other nucleotide units (H20 < H20 0). The resonance assignments
of backbone 31P and sugar ring 1H (H40 and H30) resonances for
free and mono-ruthenated DNA duplexes were achieved by [1H,
31P] HSQC NMR experiments61 and the H40n and H30n1 protons
were assigned by correlation to their respective 31Pn resonances.
The assignments of ruthenated G*H8 and 10-en-NH2 1H (NHu
and NHd, see Fig. 1 for labelling) resonances of mono-ruthen-
ated DNA duplexes were achieved by reference to 2D [1H, 15N]
HSQC and 15N-edited [1H, 1H] NOESY NMR data. The NMR
chemical shifts of the 1H and 31P resonances associated with these
two mono-ruthenated duplex adducts are listed in Table S3 (II-
Ru-G3), Table S4 (II-Ru-G6) and Table S2 (free II).† The
assignments of H1,4, H2,3, H9,10, H5,8, H6,7 and 10-en-NH2
(NHu and NHd, see Fig. 1 for labelling) 1H NMR resonances of
{(h6-tha)Ru(en)}2+ (10) were achieved by 2D [1H, 15N] HSQC,
15N-edited [1H, 1H] NOESY and [1H, 1H] NOESY experi-
ments27,28 and are listed in Table 1 and Fig. 5. The assignments of
H2,3 and H1,4 NMR resonances of 10 were achieved by corre-
lations to the 10-en-NHu resonances in [1H, 1H] NOESY NMR
data, where the H9,10 protons were assigned by correlation to
the H1,4 resonances, and H5,8 protons by correlation to the
H9,10 and H6,7 resonances.27,28
NMR of 1.1 : 1, 2 : 1 and 3 : 1 1/II reactions
Fig. S1 shows the imino and aromatic region of the 800 MHz 1D
1H NMR spectrum of DNA duplex II in the absence (Fig. S1A†)
and presence of 1 mol (Fig. S1B†), 2 mol (Fig. S1C†) and 3 mol
(Fig. S1D†) equiv. of 1. Reaction with 1.1 mol equiv. of 1
resulted in the formation of a number of new peaks for II
(especially near 8.5 ppm (G*H8), 13.0–13.6 ppm (imino) and
Fig. 2 HPLC chromatograms for reaction of [(h6-tha)Ru(en)Cl]+ (1)
with single-stranded (ss) d(CGGCCG) (I) (0.1 mM in H2O) at Ru : I mol
ratios of (a) 1 : 1, (b) 2 : 1, and (c) 3 : 1, and for reaction of 1 with duplex
d(CGGCCG)2 (II) (0.34 mM, 0.1 M NaClO4, 90% H2O/10% D2O) at
a Ru : II mol ratio of (d) 1.1 : 1 and (e) 2 : 1. The mono-ruthenated
duplex II-Ru1 elutes as mono-ruthenated ss-DNA I (I-Ru-G
3 and I-Ru-
G6; species I-Ru-G3 and I-Ru-G9 are identical, as are I-Ru-G6 and I-Ru-
G12); di-ruthenated duplex II-Ru2 elutes as mono-ruthenated ss-DNA I
(I-Ru-G3 and I-Ru-G6, see (d)), and di-ruthenated ss-DNA I (I-Ru2, see
(e)). It is notable that G2 is readily ruthenated for single strand I (see I-
Ru-G2 in (a)) but not for duplex II in (d). Little ruthenation on G8 was
observed when 1 mol equiv. of 1 was added to mono-ruthenated duplexes
II-Ru-G3 and II-Ru-G6 (e). Ru¼ {(h6-tha)Ru(en)}2+ (10), and is bound to
G3N7 or G6N7; for DNA sequence, see Fig. 1 and Scheme 1.
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6.3–6.7 ppm (NHu-10, 10 is the bound complex 1, {(h6-tha)-
Ru(en)}2+), Fig. S1B†). Two imino 1H NMR resonances were
shifted to low-field by +0.04 ppm (G3*, mono-ruthenated G3
base) and +0.14 ppm (G9), and two imino 1H resonances were
shifted to high-field by 0.07 ppm (G6*, mono-ruthenated G6
base) and0.04 ppm (G12), relative to the free duplex II (Figs. S1
and S2, Tables S3, S4 and S2†). Reaction of the second mol
equiv. of 1 with the mono-ruthenated duplexes resulted in
a notable increase in intensities of the new peaks, especially
G*H8 (near 8.5 ppm), NHu-10 (6.3–6.7 ppm), H5 and H10
resonances; the intensities of imino and H8, H6 resonances of
free II all decreased (Fig. S1C†). Reaction of the third mol equiv.
of 1 with the di-ruthenated duplexes resulted in an increase in the
intensities of new peaks, e.g. at 8.8 ppm (Fig. S1D†). The reso-
nances of CH5, CH6, H10 and G*H8 moved to low field by up to
+0.3 ppm, and the peaks for imino protons almost disappeared.
2D [1H, 1H] TOCSY NMR of 1.1 : 1, 2 : 1 and 3 : 1 1/II
reactions
The 2D TOCSY NMR spectrum of the 1.1 : 1 1/II reaction
mixture clearly showed the existence of cross-peaks for the two
mono-ruthenated duplexes, as seen for example in the aromatic
region in Fig. 3B. Two sets of H5-H6 cross-peaks were detected
for C4, C5, C7 and C10 residues. The proportions of Ru-IIa and
Ru-IIb at 283 K were determined by integration of the TOCSY
cross-peak volumes of C4-H5/C4-H6 of Ru-IIa, and C5-H5/C5-H6
of Ru-IIb, and the HPLC peak areas for I-Ru-G3 and I-Ru-G6
(see Fig. 2d). This gave a Ru-IIa : Ru-IIb ratio of 2 : 1 (10%).
Other species account for less than 10% of the total DNA. The
2D TOCSY NMR spectrum of the 2 : 1 1/II reaction mixture
shows that peaks for other new species are present but not all can
be assigned due to the complexity of the spectrum (Fig. 3C). It
was notable that the intensities of the CH5-CH6 cross-peaks for
C5/C11 residues of free II decreased remarkably, but those of the
CH5-CH6 cross-peaks for C10, C40 and C50 residues of the
ruthenated species increased markedly. The 2D TOCSY NMR
spectrum of the 3 : 1 1/II reaction mixture shows that the CH5-
CH6 cross-peaks for C5/C11 residues of free II almost completely
disappeared (Fig. 3D).
2D [1H, 15N] HSQC NMR of the 1.1 : 1 1/II reaction
These experiments allowed detection of NMR peaks specifically
for the {(h6-tha)Ru(15N-en)}2+ fragment. These are commonly
difficult to resolve in normal 1H NMR experiments. One major
new species was detected by 2D [1H, 15N] HSQC NMR analysis
of the 1.1 : 1 mixture of duplex II and 15N-1 (the 15N-en labelled
complex 1) at 283 K in 90% H2O/10% D2O (Fig. S3†). Peaks were
assignable to en-NHu resonances (the NH protons oriented
Table 1 1H NMR chemical shifts for [(h6-tha)Ru(en)(Cl)]+ (1) and bound fragment {(h6-tha)Ru(en)}2+ (10) in the 1.1 : 1 1/II reaction product 10-II, in
Ru-tha-9EtG (10-9EtG)a,b and Ru-tha-50GMP (10-GMP) adductsa,b
Complex
d(1H) (Dd)
en-CH2 NHd H1,4 H2,3 NHu H5,8 H9,10 H6,7
1 2.23/2.43 3.60/3.71 5.50 5.61 6.19/6.29 2.62 3.18 5.75
10-IIe 2.34/2.45 (0.11/)c 3.86/3.95d (0.26/0.24)c 6.04 (0.54)c 5.97 (0.36)c 6.47/6.56 (0.18/0.27)c 2.74 (0.12)c 4.18 (1.00)c 5.84 (0.09) c
10-9EtG b,f 2.07/2.40 (0.16)h na 5.85 (0.35)h 6.24 (0.63)h na 2.55 (0.07)h 3.20 5.66 (0.09)h
10-GMP b,g 2.10/2.40 (0.13)i na 6.16 (0.66)i 6.16 (0.55)i na 3.12 (0.50)i 4.01 (0.83)i 5.65 (0.10)i
a For atom labels, see Fig. 1 and Scheme 1. b Ref. 28. c Dd ¼ d(10-II)  d(1) ($0.04 ppm). d This assignment is based on a NOESY experiment. e At 283
K. f At 339 K. g At 318 K. h Dd ¼ d(10-9EtG)  d(1) ($0.04 ppm). i Dd ¼ d(10-GMP)  d(1) ($0.04 ppm).
Fig. 3 2D [1H, 1H] TOCSY NMR spectrum in the cytosine H5/H6 cross-
peak region for free duplex II (A), 1.1 : 1 1/II mixture (B), 2 : 1 1/II
mixture (C) and 3 : 1 1/II mixture (D) of ruthenium complex 1 and duplex
II (0.34 mM, 0.1 M NaClO4) in 90% H2O/10% D2O at 283 K. Note that
2 sets of resonances are observed for the C4, C5, C7 and C10 residues,
suggesting the presence of two mono-ruthenated products in the 1.1 : 1 1/
II mixture (B). Significant changes are observed for H5/H6 resonances of
C5 and C11 bases when the Ru:II ratio is increased from 1.1 : 1 to 3 : 1,
and the H5/H6 cross-peaks of C5 and C11 bases disappear when the
Ru : II ratio reaches 3 : 1, suggesting that all the G6 and G12 bases are
ruthenated in the 1/II mixture 3 : 1. Assignment: C10, C1-H5/H6 cross-
peak of ruthenated species; C40, C4-H5/H6 cross-peak of ruthenated
species; C50, C5–H5/H6 cross-peak of ruthenated species. Assignments are
based on the 2D [1H, 1H] NOESY NMR spectrum (Tables S2–S4†) and
HPLC results (Fig. 2); for DNA sequence, see Scheme 1.
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towards the coordinated arene ring, see Fig. 1 and Table S5†) of
mono-ruthenated duplexes Ru-IIa and Ru-IIb (Ru ¼ {(h6-
tha)Ru(en)}2+ (10)). No cross-peaks for en-NHu resonances of
Ru-IIa and Ru-IIb were detectable after the equilibrium mixture
had been freeze-dried and re-dissolved in D2O at 283 K. The en-
NHd resonances of both Ru-IIa and Ru-IIb were not observed in
either H2O or D2O solutions. In contrast, the en-NHu and en-
NHd resonances of unreacted 1 were detected in 90% H2O
(Fig. S3†). The assignments are listed in Table S5.†
2D [1H, 31P] HSQC NMR of 1.1 : 1 1/II reaction
The backbone phosphate 31P (0.6 to 1.4 ppm) to sugar ring
H30 (5.3–4.6 ppm) and H40 (4.6–4.0 ppm) HSQC connectivities
for free duplex II and the 1.1 : 1 1/II reaction are shown in Fig. 4
and the assignments are listed in Tables S3 and S4.† Compared
to free duplex II, the 31P/H40 cross-peaks for C4 (peak e) and G6*
(peak i) residues, 31Pn+1/H3
0
n cross-peaks for G
2-G3* (peak d),
G3*-C4 (peak f) and C4-C5 (peak h) residues were shifted to give
new peaks, but 31P/H40 cross-peaks for G3*, C4 and C5 (peak g)
and 31Pn+1/H3
0
n cross-peaks for C
5-G6* (peak j) residues were too
broad to assign. Decreased intensities of 31P/H40 and 31Pn+1/H30n
cross-peaks were found for G2/G8 (peak b), G3/G9 (peak c), and
C4/C10 (peak d) residues. These results are consistent with the
HPLC-MS and 2D TOCSY NMR data.
2D [1H, 1H], 15N-edited [1H, 1H] NOESY NMR of products from
1.1 : 1 1/II reaction
Assignments for 1H NMR peaks of mono-ruthenated duplexes
Ru-IIa and Ru-IIb in the spectra of the 1.1 : 1 1/II reaction are
listed in Tables 1, S3 and S4,† and intermolecular NOEs in
Tables S6 and S7.† For Ru-IIa, a large low-field shift of the G3H8
resonance was observed, as was also the case for H8 of the
neighbouring G2 base and H5 and H6 of the neighbouring C4
base, relative to free duplex II (Fig. S4 and Tables S2 and S3†).
The largest changes in deoxyribose H10 chemical shifts occur for
G3*, G2 and C5 residues, with the smallest changes for the
neighbouring C4 and C10 residues (Fig. S4 and Table S3†). NOE
cross-peaks were found between G3*H8 and 10-en-NHd, 10-en-
NHu, H2,3, H1,4 and H9,10 protons, between G3*H10, G3*H20/
H20 0 and 10-H9,10 and H1,4 protons, between C4-H50, C4-H6 and
10-H9,10 and H1,4 protons, and between C4-H10 and 10-H9,10,
H5,8 protons (Figs. 5, S6 and Table S6†). NOE cross-peaks were
also found between protons of bases G9, G2 and C10 and 10. In
particular, NOE cross-peaks were observed between G9H20 0, C10-
H10 and 10-H6,7 (Figs. 5, S6 and Table S6†). Sequential
connectivities for base-to-sugar 1H NMR resonances were
obtained, but those in the G2-C3*, G3*-C4 and G9-C10 steps were
extremely weak or absent. The interruption or weakening of
NOE connectivities between sequential DNA nucleotides is
consistent with the binding of {(h6-tha)Ru(en)}2+ (10) at G3* in
the adduct Ru-IIa.
For adduct Ru-IIb, large low-field shifts were observed for the
G6*H8 resonance and for H5 and H6 resonances of the neigh-
bouring C5 residue (Fig. S5 and Tables S2 and S4†). The H6
resonance of C7 in the complementary strand, which is paired
with G6, shifted slightly to low field, but the H5 resonance shifted
to high-field relative to free duplex II. The largest changes in H10
chemical shifts were found for G8, and for C7, C5, and G6*. NOE
cross-peaks were found between G6*H8 and 10-en-NHd, 10-en
NHu, H2,3, H1,4, H9,10 and H5,8 protons, between G6*-H10
and 10-H9,10, H5,8 and H6,7 protons, and between G6*-H40,
G6*-H50 and 10-H9,10 and H5,8 protons (Figs. 5, S6 and Table
S7†). NOE cross-peaks were also detected between protons of the
bases C5, G8, C7 and bound fragment 10 (Figs. 5, S6 and Table
S7†). Particularly of note were cross-peaks observed between C7-
H20 and 10-H6,7, C7-H20 0 and 10- H5,8. Sequential base-to-sugar
connectivities were obtained, but those in the C4-C5, C5-G6* and
C7-G8 steps were extremely weak or absent. The interruption or
weakening of NOE connectivities between sequential DNA
nucleotides is consistent with the binding of 10 at G6* in the
adduct Ru-IIb.
Only one set of signals was observed for the bound fragment
{(h6-tha)Ru(en)}2+ (10) in the two ruthenated duplexes Ru-IIa
and Ru-IIb (Figs. 5, S6† and Table 1). Compared to the unbound
chloro form of 1, peaks for 10-H1/H4 and H2/H3 of the coordi-
nated arene (see Fig. 1 for labelling) were shifted to low-field, the
largest shift being for 10-H1/H4 (Table 1). Peaks for 10-H9/H10,
H5/H8 and H6/H7 of the non-coordinated rings were shifted to
low-field by +1.00, +0.12 and +0.09 ppm, respectively, the largest
shift being for 10-H9/H10 (Od¼ +1.00 ppm). Two sets of slightly
Fig. 4 2D [1H, 31P] HSQC NMR spectra of (A) duplex II and (B) 1.1 : 1
1/II mixture (0.34 mM, 0.1 M NaClO4 at 283 K, pH 7.0) in 90% H2O/10%
D2O, showing the backbone
31P (1.4 to 0.60 ppm) to sugar ring H30
(5.2–4.6 ppm) and H40 (4.6–4.0 ppm) connectivities. The circles indicate
Cn-31P/H40, Cn-31P/Cn1-H30 and Cn-31P/Gn1-H30 or Gn-31P/H40, Gn-31P/
Gn1-H30 and Gn-31P/Cn1-H30 assignments. Note the disappearance of
cross-peaks g and j, downfield shift of cross-peaks d, e, f, h and i to give
new peaks d*, e*, f*, h* and i*, respectively, and decrease in intensity of
cross-peaks c, d and f after ruthenation of G3N7 (Ru-IIa) and G6N7 (Ru-
IIb). For DNA sequence, see Scheme 1.
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low-field-shifted or unchanged signals for 10-en CH2 of both Ru-
IIa and Ru-IIb were detected. Two sets of signals for both 10-en-
NHd and en-NHu protons of Ru-IIa and Ru-IIb were observed,
and the peaks for 10-NHd and NHu were shifted to low-field, the
largest shift being for 10-NHu. One set of signals from unreacted
ruthenium complex 1 was observed in the 1.1 : 1 1/II reaction
mixture (Fig. S7† and Table 1). These results are consistent with
ROESY experiments (data not shown).
Discussion
Complex 1 selectively ruthenates guanine bases in single strand
DNA I or duplex II (Fig. 2a–c) with a similar pattern to that
observed for the biphenyl (bip) and p-cymene (cym) complexes.22
Complex 1 is as reactive towards duplex II as the Ru-bip
complex, and much more reactive than the Ru-cym complex.
This pattern of reactivity was observed previously with calf
thymus DNA, for which t50% values of 10 min, 10 min and 3.5 h
for complexes 1, Ru-bip and Ru-cym, respectively, were found.26
Precipitation of adducts was observed when >1 mol equiv. of
Ru-bip or Ru-cym complex was added to duplex II (0.2 mM).22
However, no such behaviour was observed in the present work.
Addition of up to 3 mol equiv. of complex 1 to duplex II, even at
the higher concentration of 0.3 mM, did not result in precipita-
tion. This suggests that the nature of the arene influences inter-
molecular interactions. However, precipitation of adducts was
observed when >3 mol equiv. of complex 1 was added to duplex
II (0.3 mM), and was also the case when the reaction mixture of
1 + II (3 : 1) was kept at 277 K for long periods (ca. four weeks).
Intermolecular interactions are probably also influenced by the
order of occupation of the Ru sites and the extent of arene
intercalation (for tha and bip).
Determination of binding sites by NMR
The 31P chemical shift changes determined from the 2D [1H, 31P]
HSQC NMR experiment are consistent with ruthenation at N7
of the G residues of the 6-mer DNA duplex II by 1. Binding of
Ru-bip to the phosphate of 50-GMP27,28 causes a low-field shift of
the 31P NMR resonance by up to +5.11 ppm. However, the
binding of Ru-bip to N7 of 50-GMP,28 50-IMP or 50-cGMP
caused low-field 31P NMR shifts of less than 1 ppm. Similarly,
ruthenation of 50-GMP by trans-[RuCl2(DMSO)4] giving Ru–
OPO3 coordination causes a +5.8 ppm
31P downfield shift,62 and
direct Pt–OPO3 binding to IMP produces a
31P downfield shift of
about +3.5 ppm.63 The formation of N7-ruthenated complexes of
50-GMP and 50-IMP, N6- or N4-ruthenated complexes of 50-
AMP or 50-CMP by {Ru(III)(NH3)5}3+ gave rise to little change in
31P resonances of the nucleotides.64 Therefore, it is evident that
direct coordination of RuII to a phosphate oxygen induces a 31P
chemical shift change of ca. +5 ppm, while coordination to GN7
and no direct binding to phosphate oxygen induces a chemical
shift change in the range of 0–1 ppm. In the present case, the
most affected signals are assigned to the phosphate groups of
residue C4 (Dd +0.09 ppm) and residue G6* (Dd 0.05 ppm)
(Fig. 4 and Tables S3 and S4).† Other 31P resonances are shifted
by less than 0.03 ppm. Significant changes were observed for 31P,
H30 and H40 resonances of residues G3*, C4, C5 and G6*; minor
Fig. 5 Part of the 2D [1H, 1H] NOESY NMR spectrum of the 1 : 1 equilibrium mixture of duplex II and complex 1 (0.34 mM, 0.1 M NaClO4, 90% H2O/
10% D2O at 283 K, pH 7.0, mixing time 400 ms). Cross-peaks: a, G
9H10/10-H6,7; b; C10H10/10-H6,7; c, G8H10/10-H6,7; d, C7H10/10-H6,7. The observed
intermolecular {(h6-tha)Ru(en)}2+-II cross-peaks from mono-ruthenated product II-Ru-G3 are: G3*H8/10-enNHu, G3*H8/10-enNHd, G3*H8/10-H9/10,
G3*H8/10-H1,4, G3*H10/10-H9/10, G3*H10/10-H1,4, C4H6/10-H1,4, C4H6/10-H9,10, C4H5/10-H9,10, G9H10/10-H6,7, C10H10/10-H6,7; and from II-Ru-G6
are: G6*H8/10-enNHu, G6*H8/10-enNHd, G6*H8/10-H9/10, G6*H8/10-H1,4, G6*H10/10-H9/10, C5H6/10-H1,4, G8H10/10-H6,7, C7H10/10-H6,7. Cross-
peaks within the ruthenated guanine residues G3* or G6*, and within the bound ruthenium complex 10 are also indicated. Labels: 10 ¼ {(h6-tha)-
Ru(en)}2+; ruthenated guanines are marked with asterisks. For NMR chemical shifts, see Tables S2–S4,† and for atom labels, see Fig. 1.
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changes observed for the corresponding resonances of C1/C7 and
G2/G8 further indicated that the binding site was N7 of G3* or
G6*. Selective binding to N7 of the G residues of double-stranded
DNA duplex II was evident from the 15N-edited [1H, 1H] NOESY
NMR spectrum and confirmed by 1H NMR chemical shift
changes (Figs. 5, S6 and Tables S3 and S5†). NOE connectivities
between ruthenated G*H8 and 10-NHu or 10-NHd were observed
in the 15N-edited [1H, 1H] NOESY and 15N-decoupled [1H, 1H]
NOESY NMR spectra. Binding of 1 to 9-ethylguanine and 50-
GMP27 via N7 causes a low-field shift of the H8 1H NMR reso-
nance by up to +0.6 ppm. Binding of Ru-cym and Ru-bip
complexes to 6-mer single strand DNA I or duplex II23 via N7
causes low-field shifts of the H8 1H NMR resonance of +0.49 to
+0.66 ppm, and +0.28 to +0.58 ppm, respectively. Similar shifts
were observed for the H8 resonances of G bases in the hexamer,
and allow assignment of the binding sites as G3* (Od H8 + 0.59
ppm) in Ru-IIa and G6* (Od H8 + 0.46 ppm) in Ru-IIb present
in the 1.1 : 1 reaction mixture of 1 + II (Figs. S1, S4 and S5,
Tables S3 and S4†). With the binding fragment {(h6-tha)-
Ru(en)}2+ (10), the mono-ruthenated duplex Ru-IIa is assigned
as II-Ru-G3(10), Ru-IIb as II-Ru-G6(10) (for DNA sequence,
see Scheme 1).
The ruthenation of duplex II by complex 1 mainly caused low-
field shifts of imino proton resonances of G residues G3* and G9
in II-Ru-G3(10), but high field shifts of imino proton resonances
of G residues G6* and G12 in II-Ru-G6(10) (Fig. S2 and Tables S3
and S4†). In contrast, the imino proton resonances of the mono-
intercalated duplexes and di-intercalated duplex ruthenated with
Ru-bip are broad and weak, implying that the base-pairs are
disrupted in the duplex with an increase in dynamic mobility of
the bases.23 High-field shifts of imino proton resonances were
found for mono-ruthenated species in the 1 : 1 reaction mixture
of Ru-cym complex + II, and platination of the 14-mer duplex
d(TATGTACCATGTAT)/d(ATACATGGTACATA) also
causes high field shifts of G imino proton resonances.23,59
Structural perturbations induced by ruthenation with complex
1 are larger than those observed for Ru-bip and Ru-cym
complexes,23 and are localized to within a few (2) base-pairs of
the ruthenation site in all cases for complex 1, while only the two
adjacent bases (C4 and C10 or C5 and C7) are affected by ruthe-
nation at G3* or G6* in all cases for Ru-bip and Ru-cym adducts.
Not only were large low-field shifts of the H5 and H6 resonances
observed for C4 in II-Ru-G3(10) and C5 in II-Ru-G6(10), but also
for H10 of G2, G3, C4, C5 and C11 in II-Ru-G3(10), and of C5, C7
and G8 in II-Ru-G6(10) (Tables S3 and S4†).
Intercalation
Literature reports show that intercalation into DNA base pairs
can often be recognised by distinctive features,19,22,23,49,54,61,65
including (a) upfield 1H NMR shifts of resonances of the inter-
calator; (b) NOE cross-peaks between protons of the intercalator
and DNA bases at sites of intercalation; (c) the interruption or
weakening of NOE connectivities between sequential DNA
nucleotides; (d) the absence or weakening of the correlation
peaks of H30n-31Pn+1 and H30n-31Pn at sites of intercalation steps
and the large chemical shift perturbations at the intercalation
steps; and (e) the weakening of the strength of H-bonding
between en-NH and GO6 in the case when the ruthenium
complex Ru-bip with an extended arene ring system was
involved.22,23
It is notable that no large high-field shifts of proton resonances
of 10 were detected, but large low-field shifts up to +1.00 ppm
were observed for protons H9,10, H5,8 and H6,7 of rings B and
C in the mono-ruthenated duplexes II-Ru-G3(10) and II-Ru-
G6(10) (Table 1). These shifts are inconsistent with shielding
effects from the ring-currents of nucleobases which form
a sandwich with the intercalated non-coordinated rings of bound
10, and so do not provide evidence for intercalative
binding.19,49,54,65 For example, upfield shifts of between 0.4 and
1.0 ppm have been reported for Ru-bip intercalated into 6-mer
or 14-mer duplex DNA,22,23 and upfield shifts of 0.1 to
1.0 ppm for the intercalated dap (1,12-diazaperylene) ligand
of the dirhodium(II) carboxylate complex [Rh2(dap)(CH3-
COO)3(CH3OH)3] into a 12-mer duplex DNA.
19 Such large low-
field shifts of the bulky tha intercalator have not been observed
for other bulky intercalators, for example, large high-field shifts
have been observed for bulky intercalated cholesterol groups.44
However, similar large low-field shifts for proton resonances of
10-9EtG were found for the adduct [(h6-tha)Ru(en)(9EtG)];28 the
H5,8 and H6,7 resonances slightly shifted to high-field, but the
H9,10 resonances remained unchanged. In the case of [(h6-
tha)Ru(en)(50-GMP)] (10-GMP),28 H9,10 and H5,8 resonances
are shifted to low-field by +0.83 and +0.50 ppm, respectively, and
the H6,7 resonances shifted to high-field by 0.10 ppm. In the
present case of the mono-ruthenated duplexes II-Ru-G3(10) and
II-Ru-G6(10), H9,10, H5,8 and H6,7 resonances shifted to low-
field by +1.00, +0.12 and +0.09 ppm, respectively. Thus it is
reasonable that the resonances of intercalated non-aromatic
rings B and C of tha in the mono-ruthenated duplexes II-Ru-
G3(10) and II-Ru-G6(10) shift to low field.
The single crystal X-ray structure of (10-GMP)28 shows that ring
C of 10 is tilted towards the purine by 27.8 and lies directly over
the purine base, indicative of strong intramolecular p–p stacking
between ring C and the purine ring with a centroid–centroid
separation of 3.45 A and dihedral angle of 3.3. Intercalation of
the non-coordinated rings of 10 into the DNA duplex is also
consistent with circular and linear dichroism data.26,29 Due to
excessive resonance broadening, the resonances for protons that
intercalate between purine rings are difficult to assign. Weak to
intermediate intensity NOE cross-peaks were found not only
between the rings of bound 10 and H10 or H8 protons of G3* or C4
in II-Ru-G3(10), but also between the rings of 10 and G9 and C10
(Figs. 5, S6 and Table S6†). This can happen if the intercalation
occurs not only at the G3pC4 base step, but also at the G9pC10 base
step. The intermediate intensity cross-peaks observed between
G9H200 or C10H10 and 10-H6,7 protons, indicate that the extended
rings of 10 intercalate deeply and are located between the middle of
G9 and C10 bases. Analogous NOE cross-peaks between the rings
of bound 10 and H10, H8, H20 and H20 0 of G6* in II-Ru-G6(10), and
also between rings of 10 and C5, C7 and G8 were detected, indi-
cating that intercalation occurs between G6* and C5, and between
G8 and C7 as well (Figs. 5 and S6, and Table S7†). The intermediate
intensity cross-peaks observed between G6 or C5 and 10-H1,4
protons, indicate that the coordinated arene ring of 10 is located
between the middle of G6 and C5 bases. Additionally, intermediate
intensity cross-peaks observed between C7H20 and 10-H6,7
and C7H200 and 10-H5,8 protons indicate that the extended rings of
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10 intercalate deeply and are located near to the C7 base. The
interruption of NOE connectivity pathways between the corre-
sponding base pairs (G2-C3*, G3*-C4 and G9-C10 steps in II-Ru-
G3(10), and C4-C5, C5-G6* and C7-G8 steps II-Ru-G6(10)) is
consistent with these intercalation sites.
The absence of the H30n-Pn+1 cross-peaks linking the C5-G6*
step and the H30-P cross-peaks of G3*, C4 and C5, the low field
shifts for H30n-Pn+1 cross-peaks linking G2-G3*, C4-C5 and G3*-
C4, and for H30-P cross-peaks of C4/C10 and G6, and the large
chemical shift perturbations at the G2-G3* and C5-G6* steps,
together indicate that the intercalation occurs between G3pC4 or
C5pG6 base steps (Fig. 4).62 Previous work has shown that the
intercalation sites of the non-coordinated phenyl ring of Ru-bip
in mono-ruthenated duplexes4c are also between G3pC4 or C5pG6
base steps.
No cross-peaks for en-NHu resonances of Ru-IIa and Ru-IIb
were detected after the 1.1 : 1 1/II reaction mixture had been
freeze-dried and re-dissolved in D2O. This suggests that the
hydrogen bond between G*O6 and en-NH of 10 is weakened
(Fig. S3 and Table S5†), which is consistent with intercalation of
the non-coordinated rings of 10 into duplex DNA II. Similarly
weakened hydrogen bonds were also observed when the biphenyl
ring of Ru-bip intercalates into the hexamer duplex.22 The
strength of the H-bond between G*O6 and en-NH is related to the
decay rate of the en-NH signals when II-Ru adducts are dissolved
in 99% D2O.
22 For the non-intercalated adduct with Ru-cym, the
half-life was 72 h. However, those of the mono- and di-interca-
lated Ru-bip adducts were only 5 h and <0.1 h, respectively.
NMR studies show that the arene–nucleobase p–p stacking of
10 with hexamer duplex is different from that of Ru-bip.22,23 Only
a very few weak NOE contacts between protons of ring B of
biphenyl and H10 and H20/H20 0 protons of G3* or C4 of the
hexamer duplex are observed.22 The protons Ho0, Hp0 and Hm0
of bound Ru-bip in the DNA duplex adducts were consistently
shielded relative to free Ru-bip, consistent with base stacking of
the non-coordinated ring B between base pair G3*pC4. However,
in the present case, not only were weak to intermediate intensity
NOE contacts detected between protons of rings B and C of tha
and protons of G3* and C4 or G6* and C5, but also intermediate
intensity NOE contacts were detected between protons of ring C
of tha and protons of G9 and C10 or C7 and G8 DNA bases which
pair with G3* or C4, G6* or C5 in the complementary DNA strand
(Fig. 5, Tables S6 and S7†), respectively. This indicates that rings
B and C of tha are involved in a penetrative intercalation
between two pairs of bases, G3/C10:C4/G9 or G6/C7:C5/G8. It is
interesting that large low-field shifts, but not large high-field
shifts are observed for the proton resonances of intercalated rings
B and C of 10, indicating that the intercalative interactions
between Ru-tha and Ru-bip with the DNA duplex are signifi-
cantly different from one another. The ring current shifts are
position-related: upfield shifts only arise when the protons are
above or below the ring plane. In contrast, resonances for
protons located close to the plane and beyond the confines of the
ring are shifted to low field.66
Modelling of II-Ru-G3(10) and II-Ru-G6(10)
In order to attempt to rationalize the NOE and chemical shift
information gathered for II-Ru-G3(10) and II-Ru-G6(10), two
molecular models were constructed in which the duplex
d(CGGCCG)2 was ruthenated at N7 of G
3 or G6 by 10, as shown
in Fig. 6. The II-Ru-G3(10) (Fig. 6a–c) and II-Ru-G6(10) (Fig. 6d–
f) models are mostly consistent with the NMR observations, and
overwhelming evidence indicates that a penetrative interaction
occurs between rings B and C of 10 and duplex DNA at G3/
C10:C4/G9 or G6/C7:C5/G8, respectively. The model also provides
a useful indication of how 10 may lie in relation to its DNA
binding site. The H5,8 and H9,10 protons of 10 are located above
or below the ring plane and the distances between H5,8 or H9,10
protons and purine or pyrimidine rings of G or C bases are nearly
0.9 A shorter than the case of aromatic intercalators, such as Ru-
bip. Compared to the structural findings for aromatic inter-
calators, both structures (II-Ru-G3(10) and II-Ru-G6(10)) suggest
distortion of bases-pair planes around the site at which the tha
has penetrated and the system is likely to be highly dynamic in
and around the intercalation sites. The dynamics of II-Ru-G6(10),
in which the Ru binds to a terminal, potentially frayed nucleo-
tide, would be expected to be significantly different compared
with those for II-Ru-G3(10), in which the Ru binds to the internal
base.
The data imply that in both cases the tha of 10 in the models
has swung round so that the ring system points across to the
opposite strand rather than penetrating so deeply into the strand
to which the Ru centre is attached (G3* or G6*). This supports the
NOE contacts observed between protons of rings A and B of 10
and H10 and H8 or H6 protons of G3, C4 or C5, G6 and in
particular between H6,7 protons of ring C of 10 and the H10, and
H20 protons of residue C10, G9 or G8, C7 of the complementary
Fig. 6 Molecular models of duplex II ruthenated at N7 of G3 or N7 of
G6 with {(h6-tha)Ru(en)}2+. (a)–(c) II-Ru-G3 showing the intercalation of
the tetrahydroanthracene ligand between G3/C10:C4/G9. (d)–(f) II-Ru-G6
in which the non-arene rings are intercalated between G6/C7:C5/G8. In
each case side and top views of the intercalation site are shown as well as
the whole duplex (bottom). Colour code: tha green, Ru purple, P yellow,
O red.
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strand (see Tables S6 and S7,† Fig. 6). In contrast in models for
Ru-bip, the non-coordinated phenyl ring of the biphenyl ligand
penetrates deeply at the G3*pC4 or G6*pC5 base step. The relevant
inter-proton distances are consistent with the observed NOE
contacts. Observed NOE data are consistent with the model of
II-Ru-G3(10): NOEs occur between H1,4 (3.45 A), H9,10
(4.73 A), H2,3 (3.72 A) and G3*H8, respectively; between
H9,10 (4.74 A) or H1,4 (4.64 A) and G3*H10, respectively;
between H9,10 (3.71 A) or H1,4 (3.24 A) and C4H6, H5,8
(3.60 A) or H9,10 (4.14 A) and C4H10, respectively; between
H6,7 (3.67, 3.18 or 2.52 A) and G9H10, -H20 or -H200, respec-
tively; between H6,7 (2.94 or 2.69 A), H5,8 (3.08 A) and
C10H6 or C10H10, respectively and NHd (2.49 or 3.03 A) and
G2H8 or -H20 in the model, respectively. Observed NOE data are
also consistent with the model II-Ru-G6(10): medium and weak
NOEs occur between H1,4 (2.74 A) or H9,10 (2.86 A) and
G6*H8, respectively; between H5,8 (2.55 A), H9,10 (3.47 A)
and G6*H10, respectively; between H1,4 (2.87 A) and C5H6,
H1,4 (3.72 A) and C5H10, H1,4 (2.66 A) and C5H20, respec-
tively; between H6,7 (2.44 A) and C7H20, H6,7 (2.94 A) and
C7H10, H6,7 (3.01 A), H5,8 (2.53 A) and C7H20 0, H6,7 (3.44
A), H5,8 (3.50 A) and G8H10, H5,8 (3.85 A), H6,7 (3.89 A)
and G8H20/H20 0 in the model, respectively. As shown in Fig. 6,
the shortest distance for enNH/O6G3 or enNH/O6G6 is 2.66
or 2.01 A, larger than that in the reported 9EtG adduct (1.91
A),28 consistent with weak en-NH resonances observed for II-
Ru-G3(10) and II-Ru-G6(10) in D2O.
The largest downfield shift (+1.00 ppm) is observed for H9,10
protons of ring B of 10 for mono-ruthenated duplexes II-Ru-
G3(10) and II-Ru-G6(10) (Table 1), but the shift changes for H6,7
(+0.09 ppm) and H5,8 (+0.12 ppm) of ring C of 10 are rather
small when compared with that for H9,10. These results are
consistent with the base stacking of the non-coordinated rings
and formation of short C–H/X (X¼ O or N)67 hydrogen bonds
between the protons of non-coordinated rings and bases as
shown in models II-Ru-G3(10) and II-Ru-G6(10) (Fig. 6). It is
clear that H5,8 and H6,7 protons are located within the confines
of the purine ring G9 in model II-Ru-G3(10) or G6 in II-Ru-G6(10),
and the H9,10 protons are located exactly in the middle of the
two strands (Fig. 6) and in the ring planes beyond the confines of
the purine or pyrimidine rings.
It has been reported that proton chemical shifts may change by
up to +2.1 ppm (downfield) on formation of C–H/X (X ¼ O or
N) hydrogen bonds.68 It is clear in the present case that the
protons of rings B and C do sit near the edge of the purine or
pyrimidine rings from the models II-Ru-G3(10) and II-Ru-G6(10),
and the protons are not directed to the centres of these rings.
Other than the fact that protons of ring B are within the arene
ring plane in Ru-bip, the H5,8 and H9,10 protons of 10 are
located above or below the ring plane in the models. Such
orientation makes the distances between H5,8 or H9,10 and N or
O atoms of purine or pyrimidine rings of G or C bases nearly 0.9
A shorter than those of Ru-bip. For model II-Ru-G3(10): short
H9,10/N1 of G3 (2.68 A), H9,10/N3 of C4 (2.51 A),
H5,8/N1 or N7 of G9 (2.70 or 2.75 A, respectively), H5,8/
OC2 of C4 (2.60 A), H6,7/sugar O of G9 (2.58 or 2.80 A,
respectively) distances are observed (Fig. 6a–c). For model II-
Ru-G6(10): short H9,10/N9 of G6 (2.66 A), H9,10/N3 of C5
(2.54 A), H5,8/N3 of G6, C7 and G8 (2.60, 2.61 or 2.61 A,
respectively), H6,7/OC2 of C7 (2.59 A) distances are observed
(Fig. 6d–f). Thus, in the present case, the shifts of the protons of
rings B and C of 10 reflect both the downfield shift induced by the
formation of C–H/X (X ¼ O or N) hydrogen bonding,68 and
the upfield shift induced by the intercalation effect on the protons
located above or below the intercalator, due to the ring current
effect of the aromatic groups. The H9,10 protons are located
exactly central to the two strands of DNA, so the downfield shifts
for H9,10 protons are larger (1.0 ppm).
The data imply that in both cases the tha of 10 in the models
has swung round so that the ring system points across to the
opposite strand rather than penetrating so deeply into the strand
to which the Ru centre is attached (G3* or G6*). This tendency is
then likely to be stabilized by tha–base interactions and C–H/X
(X ¼ O or N) hydrogen bonding within the G3-tha ring-C4 and
the G9-tha ring-C10 ‘sandwich’ as shown in Fig. 6a–c, or within
the G6-tha ring-C5 and the G8-tha ring-C7 ‘sandwich’ as shown in
Fig. 6d–f. This kind of intercalation distorts the DNA more than
that of aromatic intercalators, such as Ru-bip, and reduces the
strength of H-bonding between en-NH and G3O6. The interca-
lation of the non-coordinated phenyl ring of Ru-bip,22 of acti-
nomycin D (ActD) and daunomycin65 between the GC step in
previous work suggested that steric crowding at the GpC step is
less than that at the GpG step, which thereby allows accom-
modation of the bulky non-aromatic rings of tha. A further
driving force for GpC rather GpG intercalation is the weaker
purine–pyrimidine p–p stacking interaction for GpC compared
with purine–purine GpG steps.65 It is interesting in the present
work that all of the intercalation of Ru-bound tetrahydroan-
thracene occurs between GpC base steps, and there is no evidence
for intercalation at the GpG base steps.
Ru-en-NH/GO6 H-bonding
Two distinct NHu-NHd cross-peaks were identifiable in the
283 K 2D NOESY and 2D 15N-edited NOESY NMR spectra
(Table S5 and Figs. 5, S6†), and the downfield shifts of NH
resonances in the adducts are consistent with the presence of H-
bonding to the C6 carbonyl of the coordinated G.22,23,27,28 Only
one broad peak for NH(u) was detected in the 2D [1H, 15N]
HSQC NMR data at 283 K; the resonance for NH(d) was too
broad to observe (Fig. S3†). NH exchange was rapid for the en-
NH(u) protons in the mono-intercalated duplexes II-Ru-G3(10)
and II-Ru-G6(10) (no 1H/15N cross-peaks being detected for
a D2O solution of II-Ru-G
3(10) and II-Ru-G6(10), Fig. S3†). Such
a rapid NH exchange of the en-NH(u) protons was also observed
in the double-intercalated duplex II-Ru2-G
3G9(Ru-bip),22 sug-
gesting that mono-intercalation of 10 into duplex II gives rise to
similar effects to that of the di-intercalation of Ru-bip.
Sequence specificity of G metallation
Adducts of duplex II eluted as single strands from the reverse-
phase HPLC column22,23 (Fig. 2d and 2e) due to the denaturing
character of the HPLC solvent. Three mono-ruthenated prod-





detected in the 1 : 1 1/I reaction mixture, showing that all three
guanine bases can be ruthenated readily in the single-stranded
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hexamer DNA d(CGGCCG) (Table S1†). Only the two mono-
ruthenated products II-Ru-G3 and II-Ru-G6 were detected in the
reaction of duplex II with 1 at a Ru : II molar ratio of 1 : 1; no G2
ruthenated adduct was detected (Table S1†). When the above
mono-ruthenated products II-Ru-G3 and II-Ru-G6 were reacted
with a second mol equiv. of 1 at the same temperature, only two
mono-ruthenated single strand adducts (I-Ru-G3 and I-Ru-G6)
and two di-ruthenated single strand adducts (likely to be I-Ru2-
G3G6 and I-Ru2-G
2G6) eluted from the reverse-phase HPLC
column (Table S1†). The products may therefore involve ruthe-








3G12. No G8 ruthenated duplex adducts such as II-Ru2-
G3G8 or II-Ru2-G
6G8 were detected. These results are consistent
with 2D TOCSY experiments (Fig. 3): the cross-peak intensities
of C-H5/H6 (C10, C40 and C50) of ruthenated species increased in
the 2 : 1 1/II reaction mixture.
The cross-peaks for H5/H6 resonances of C5/C11 almost dis-
appeared when the Ru : II ratio was raised to 3 : 1 (Fig. 3D).
This might suggest that the third ruthenation site for the di-
ruthenated duplexes occurs at the un-ruthenated G6 and G12
residues, to form two tri-ruthenated duplex adducts: II-Ru3-
G3G6G12 and II-Ru3-G
2G6G12. Thus, ruthenation of mono-
ruthenated products II-Ru-G3 and II-Ru-G6 might result in three




6G9 (Scheme 1, Table S1†). The HPLC, MS and 2D
15N-decoupled [1H, 1H] TOCSY NMR data indicate that the
selectivity of G base ruthenation for the free duplex II, mono-
ruthenated duplexes and di-ruthenated duplexes is quite
different. For free duplex II, little ruthenation of G2 was
observed; for mono-ruthenated duplexes II-Ru-G3 and II-Ru-
G6, little ruthenation of G8 was observed; however, the favoured
ruthenation site for the di-ruthenated duplexes appears to be G6
and G12, the G bases at the 30 end. Reactions of complexes Ru-
cym and Ru-bip with duplex II d(CGGCCG)2 at a Ru : II ratio
of 1 : 1, also gave rise to little ruthenation of G2.22 However, the
II-Ru-G3 : II-Ru-G6 ratios in the reaction mixtures with Ru : II
ratio of 1 : 1 are different: 1 : 1 for Ru-cym, 3 : 1 for Ru-bip and
2 : 1 for Ru-tha in the present case, indicating that there is no
preference for binding to an internal base or terminal nucleotide
for the non-intercalator Ru-cym. In contrast, obvious specificity
exists for binding to an internal base for the aromatic intercalator
Ru-bip. Specificity for internal bases is also the case for the non-
aromatic intercalator Ru-tha. Exclusive attack on the 30-G (G3),
as seen for these organometallic Ru arene complexes, is
uncommon for platination. There might be two reasons for this.
Firstly, the pseudo-octahedral coordination site on an arene RuII
complex is more sterically demanding than that of a square-
planar site on PtII. In addition, the steric hindrance around each
base in DNA sequences is quite different. The combined steric
hindrance of G and C plus the RuII complex are likely to account
for a preferential binding to G3N7 or G6N7 rather than to G2N7
in the free duplex. After ruthenation at G3 or G6, the situation for
the non-ruthenated single strand in the mono-ruthenated prod-
ucts II-Ru-G3 and II-Ru-G6 may be similar to that of the free
duplex, so no G8 ruthenation is detected. For the mono-
ruthenated single strand I-Ru-G3 or I-Ru-G6 in the mono-
ruthenated products II-Ru-G3 and II-Ru-G6, steric hindrance
around G2 in the mono-ruthenated duplex II-Ru-G3 is much
greater than that in the free duplex and for this reason it is
believed that no II-Ru2-G
2G3 species is detected. The DNA
distortion caused by ruthenation at N7 of G6 may decrease the
steric hindrance around G2 in the mono-ruthenated duplex II-
Ru-G6, resulting in formation of the G2-bound di-ruthenated
duplex II-Ru2-G




G6G9 is even greater, so ruthenation at the end base G6 or G12 as
the third site is reasonable.
Bulky lesion and penetrative intercalation
Reported data44 show that the intercalative binding of a bulky
intercalator cholesterol group on a modified base of a duplex
DNA is a classical intercalation, and the lesion site and the
distortions in the structure of the DNA produced by these
cholesterol derivatives are somehow similar to those induced by
other adducts containing polycyclic aromatic groups. However,
the base opposite the modified nucleotide is displaced and the
local structure of the double helix is highly distorted. These
observations are quite different from those in the present work
involving penetrative intercalation of tha into duplex DNA when
Ru-tha is coordinated at GN7. It is notable that there is no
displacement of the base opposite the modified nucleotide, but
C–H/X (X ¼ O or N) hydrogen bonding between protons of
ring C of tha and O or N atoms of bases opposite the ruthenated
nucleotides. The local structure of the ruthenated double helix is
highly distorted. Such a highly distorted double helix is not
observed in the DNA adducts of platinum complexes with an
acridine side arm intercalator, e.g. PT-ACRAMTU,56 where the
threading intercalation occurs at the central base-pair step but
does not cause helical bending.
Experimental section
Materials
Organometallic ruthenium(II) complex [(h6-tha)Ru(en)Cl][PF6]
(1PF6) (tha ¼ 1,4,9,10-tetrahydroanthracene, en ¼ ethylenedi-
amine) and 15N-labeled 1 (15N-1) were synthesised as described
previously.27,28 The sodium salt of FPLC-purified oligonucleo-
tide d(CGGCCG) I was purchased from Oswel (Southampton,
UK) and was further purified by HPLC. Sodium perchlorate and
acetonitrile (HPLC grade) were obtained from Fisher, and tri-
ethylammonium acetate buffer (TEAA) from Fluka.
High performance liquid chromatography (HPLC)
This was carried out on reversed-phase columns with TEAA and
TEAA/acetonitrile as mobile phases.
HPLC-electrospray ionisation mass spectrometry (HPLC-
ESIMS)
Negative-ion electrospray ionisation mass spectra were obtained
on a mass spectrometer interfaced with a reversed phase HPLC
column eluted with TEAA/acetonitrile gradients as above.
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NMR spectroscopy
NMR data were acquired on an 800 MHz or 600 MHz Bruker
Avance NMR spectrometer equipped with a multiple resonance
TXI (1H, 13C, 15N, 31P) xyz-gradient probe.
Molecular modelling
A structure for canonical B-form duplex d(CGGCCG)2 was
generated within the biopolymer module of Sybyl (version 6.3,
Tripos Inc.). Crystal coordinates from the X-ray crystal struc-
tures of 1 allowed accurate representation of the Ru complex to
be incorporated into the model Ru-DNA constructs. Docking of
the Ru-complex onto GxN7 (x ¼ 3 or 6) of the DNA structure
was achieved by manual independent manipulation of both
DNA and Ru-complex molecules. The Ru-N7 inter-atomic
distance was based on reported crystal structures of Ru-GMP
complexes. A pseudo-atom at the centre of the h6-six-membered
aromatic ring (ring A) of tha was attached to the Ru centre to
provide a rotatable bond about which the tha moiety could be
manipulated. In a similar way, the Ru–GN7 bond was activated
to form a rotatable bond, about which the entire Ru ligand could
be rotated independently of the DNA structure. Ru–GxN7
models were prepared in such a way as to reduce steric contact as
far as possible. Constraints were applied where deemed plausible
and structures were energy minimized to remove the effects of
steric clash.
Details of reactions of II with 15N-1, HPLC, HPLC-ESI-MS,
NMR and pH measurements are in the ESI.†
Conclusions
In conclusion, the results presented here provide a rare example
of coordinative binding and the penetrative intercalation of
a bulky intercalator into DNA, and may help to explain why
ruthenium arene complexes have a different mechanism of
antitumour activity (perhaps related to recognition by nucleotide
repair enzymes) compared to cisplatin. Firstly, the NMR results
were indicative of the penetrative intercalation of the tha rings B
and C of 10, selectively between two base pairs G3/C10:C4/G9 or
G6/C7:C5/G8, which contrasts with that observed between one
base pair G3/C4 and or G6/C5 for the classic aromatic intercalator
Ru-bip. The two slightly different intercalation models for the
extended non-aromatic rings of Ru-tha, indicate that the
distortion of the DNA duplex is sequence-related. Secondly,
large low-field shifts for proton resonances of the intercalated
non-coordinated rings B and C of tha reflect both the downfield
shift induced by the formation of short C–H/X (X ¼ O or N)
hydrogen bonds and upfield shift induced by the intercalation
effect on the protons located above or below the intercalator, due
to the ring currents of aromatic groups. The downfield shifts of
H9,10 protons of 10 are larger (+1.0 ppm) for they are located
exactly in the middle of the two strands. Such deshielding of
intercalator NMR resonances is rare, indicating that the inter-
calative interactions between this bulky tha intercalator and
classical aromatic DNA intercalators are somewhat different.
Thirdly, the DNA structural perturbations induced by Ru-tha
are larger than those observed for Ru-bip and Ru-cym
complexes; distortions of base-pair planes are observed around
the sites at which the tha has penetrated, and the dynamics of the
terminal base ruthenated adduct II-Ru-G6(10) are significantly
different from those of internal base ruthenated adduct II-Ru-
G3(10). These findings agree with the fact that the precipitation of
DNA duplex adducts of Ru-tha is observed only at very high
concentrations compared with Ru-bip, suggesting that the
intercalation of sterically bulky tha into a DNA duplex makes
the duplex DNA behave differently from intercalation by the
aromatic bip. Fourthly, selective ruthenation at N7 of G3 and G6
in the hexamer DNA duplex is similar to that of Ru-cym and Ru-
bip, but the mono-intercalation of tha reduced the strength of
H-bonding between en-NH and GO6 as much as that for the di-
intercalated di-ruthenated Ru-bip duplex. Intercalation at GpC
by tha appears to have a lower energy penalty when compared
with intercalation at GpG base steps, thereby allowing accom-
modation of the non-aromatic, bulky rings of tha. Although all 3
G’s were readily ruthenated at N7 in the single-stranded DNA
hexamer, only G3 (or G9) and G6, and not G2 (G8) were
ruthenated in the free DNA duplex which is attributed to unfa-
vorable steric interactions22 between the duplex and arene for
binding at G2 (G8). The different ratios of II-Ru-G3 : II-Ru-G6
adducts in the reaction mixtures with Ru : II ratio of 1 : 1,
indicates that there are differences in specificity from binding to
internal bases or terminal nucleotides for the non-intercalator
Ru-cym, the aromatic intercalator Ru-bip and non-aromatic
intercalator Ru-tha. Little ruthenation of G8 was observed in the
mono-ruthenated duplexes, but the favorable binding sites were
G6 and G12 when di-ruthenated duplexes were reacted with {(h6-
tha)Ru(en)}2+. These results also demonstrate that the combi-
nation of HPLC, ESI-MS together with 2D [1H, 1H] TOCSY
NMR experiments is powerful for elucidating the selectivity of
G-base ruthenation of the free duplex II, mono-ruthenated
duplexes and di-ruthenated duplexes. Such knowledge of DNA
interactions may be incorporated into design concepts for this
class of anticancer agents and assist the exploration of structure–
activity relationships.
The coordinative and penetrative intercalative interactions
between Ru-tha and duplex DNA are different from that of
DNA modified covalently by aromatic or bulky intercalators, in
which the displacement or flip-out of bases near the modified
sites may occur. Although both involve the modification of
a DNA base via coordinative bonding, the penetrative inter-
calative interactions between Ru-tha and duplex DNA are also
different from that of platinum complexes with an acridine side
arm intercalator, where the threading intercalation does not
cause helical bending. The C–H/X (X ¼ O or N) hydrogen
bonds between protons of ring C of tha and O or N atoms of
bases opposite the ruthenated nucleotides may contribute
significantly to the intercalative interaction between Ru-tha and
duplex DNA. The fact that penetrative intercalation has rarely
been reported for mono-metallointercalators, implies that the
direct Ru–N bonding may also assist with penetrative interca-
lation for the bulky tha ligand. Unwinding and distortion, while
still maintaining the basic duplex structure, could contribute to
the toxicity of the Ru-tha complex by hindering DNA repair. A
bulky lesion is one of the six main DNA lesions that may invoke
NER, for example, the first and rate-determining step in NER is
the recognition of the bulky lesions by the XPC/HR23B protein
heterodimer complex.69 However, mutations and potentially
cancer may result if the bulky lesions are resistant to NER.70 The
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high anticancer activity both in vitro and in vivo and the high
potency of the tha complex may arise in part from the lack of
repair of the lesions formed on DNA by this complex,29 and
assist with elucidation of structure–activity relationships for this
class of complexes.
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